Shopping Cart
- Remove All
- Your shopping cart is currently empty
Besifovir, a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $45 | In Stock | |
5 mg | $135 | In Stock | |
10 mg | $197 | In Stock | |
25 mg | $328 | In Stock | |
50 mg | $488 | In Stock | |
100 mg | $713 | In Stock | |
1 mL x 10 mM (in DMSO) | $128 | In Stock |
Description | Besifovir, a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV). |
In vivo | Besifovir (LB80380) is a relatively new oral acyclic nucleotide phosphonate. Areas covered: LB80380 is a prodrug of LB80331 and LB80317. It is rapidly absorbed when taken orally. Escalating doses of besifovir produce linear increase of the plasma concentration. Doses above 60mg are effective for inhibiting HBV in human. Using 60mg as an example, the maximal concentration of LB80331 in plasma is 397 ng/mL. |
Molecular Weight | 299.22 |
Formula | C10H14N5O4P |
Cas No. | 441785-25-7 |
Smiles | C(C1(OCP(=O)(O)O)CC1)N2C=3C(N=C2)=CN=C(N)N3 |
Relative Density. | 1.94 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 250 mg/mL (835.51 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.